Results 111 to 120 of about 5,159 (186)

Intrathecal enzyme replacement therapy for CLN2 disease [PDF]

open access: yesCellular Therapy and Transplantation, 2019
openaire   +1 more source

Evolution of Movement Disorders in Patients With CLN2-Batten Disease Treated With Enzyme Replacement Therapy [PDF]

open access: yes
OBJECTIVES: Neuronal ceroid lipofuscinosis type 2 (CLN2-disease) is an inherited childhood-onset neurodegenerative condition, with classical early features of speech delay, epilepsy, myoclonus, ataxia, and motor regression.
Soo, Audrey K   +8 more
core  

A cyclin-polarity feedback network ensures healthy cell proliferation. [PDF]

open access: yesNat Commun
Peyran L   +4 more
europepmc   +1 more source

Difficulties in treating CLN2 through enzyme replacement therapy

open access: yesArquivos de Neuro-Psiquiatria, 2023
Erlane Marques Ribeiro   +8 more
openaire   +1 more source

Psychiatric manifestations in Neuronal ceroid lipofuscinoses. [PDF]

open access: yesOrphanet J Rare Dis
Della Vecchia S   +5 more
europepmc   +1 more source

Antibiotic treatment reveals the contributions of the gut microbiome to CLN2 disease in the central and enteric nervous system. [PDF]

open access: yesSci Rep
Ziółkowska EA   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy